On Problems Related to Subgroup Analyses in Clinical Trials

Publisher： Karger

E-ISSN： 2296-5262|23|4|346-351

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.4, 2000-09, pp. : 346-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statistical decisions and the interim analyses of clinical trials

By Stanev Roger  

Theoretical Medicine, Vol. 32, Iss. 1, 2011-02 ,pp. : 61-74

Springer Publishing Company

Access to resources Recommend Favorite

FDA and CPMP Rulings on Subgroup Analyses

By  

Cardiology, Vol. 107, Iss. 2, 2006-07 ,pp. : 97-102

Karger

Access to resources Recommend Favorite

Individual patient data from registrational trials of silodosin in the treatment of non‐neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data

By  

BJU INTERNATIONAL, Vol. 115, Iss. 5, 2015-05 ,pp. : 802-814

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Trials

By  

Pancreatology, Vol. 6, Iss. 6, 2007-03 ,pp. : 510-511

Karger

Access to resources Recommend Favorite

Retrospective Analyses of Cancer Trials or Existing Clinical Databases: Potential for Highly Clinically Relevant Hypothesis Generation

By  

Oncology, Vol. 83, Iss. 6, 2012-09 ,pp. : 329-330

Karger

Access to resources Recommend Favorite